Financials Indivior PLC

Equities

INDV

GB00BN4HT335

Pharmaceuticals

Real-time Estimate Cboe Europe 09:26:34 2024-07-03 am EDT 5-day change 1st Jan Change
1,190 GBX -1.73% Intraday chart for Indivior PLC -8.00% +0.62%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 377.9 1,091 2,441 3,057 2,060 2,057 - -
Enterprise Value (EV) 1 -443.1 518.3 1,581 2,523 1,983 1,770 1,470 1,130
P/E ratio 2.87 x -7.44 x 12.9 x -58.9 x 1,508 x 8.72 x 6.61 x 4.86 x
Yield - - - - - - - -
Capitalization / Revenue 0.48 x 1.69 x 3.09 x 3.39 x 1.88 x 1.63 x 1.45 x 1.32 x
EV / Revenue -0.56 x 0.8 x 2 x 2.8 x 1.81 x 1.4 x 1.04 x 0.72 x
EV / EBITDA -2 x 4.89 x 7.83 x 11.2 x 6.88 x 4.72 x 3.25 x 2.11 x
EV / FCF -2.97 x -2.63 x 4.67 x -11.1 x -4.8 x 7.07 x 5.26 x 2.38 x
FCF Yield -33.6% -38% 21.4% -9% -20.8% 14.1% 19% 41.9%
Price to Book - - - 61.1 x - 9.42 x 3.63 x 2.11 x
Nbr of stocks (in thousands) 146,153 146,701 140,437 136,489 136,551 133,984 - -
Reference price 2 2.586 7.439 17.38 22.40 15.08 15.35 15.35 15.35
Announcement Date 2/13/20 2/18/21 2/16/22 2/16/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 785 647 791 901 1,093 1,264 1,414 1,562
EBITDA 1 222 106 202 225 288 374.8 451.8 535.4
EBIT 1 202 88 187 212 269 342.8 417 504.9
Operating Margin 25.73% 13.6% 23.64% 23.53% 24.61% 27.12% 29.48% 32.32%
Earnings before Tax (EBT) 1 180 -173 190 -95 1 314.5 399.6 543
Net income 1 134 -148 205 -53 2 260.8 331.4 439.8
Net margin 17.07% -22.87% 25.92% -5.88% 0.18% 20.63% 23.43% 28.15%
EPS 2 0.9000 -1.000 1.350 -0.3800 0.0100 1.760 2.323 3.160
Free Cash Flow 1 149 -197 339 -227 -413 250.2 279.4 473.8
FCF margin 18.98% -30.45% 42.86% -25.19% -37.79% 19.8% 19.75% 30.33%
FCF Conversion (EBITDA) 67.12% - 167.82% - - 66.77% 61.84% 88.5%
FCF Conversion (Net income) 111.19% - 165.37% - - 95.96% 84.3% 107.73%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/13/20 2/18/21 2/16/22 2/16/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 222 - 221 253 276 271 293 284 301.6 320.6 344 358.8 362.5
EBITDA 1 - - - - - - - 77 78 98.5 112.9 112.5 109
EBIT 1 32 - - 71 71 60 66 70 72.5 85.75 102.4 107.5 107
Operating Margin 14.41% - - 28.06% 25.72% 22.14% 22.53% 24.65% 24.03% 26.74% 29.79% 29.96% 29.52%
Earnings before Tax (EBT) 1 - - - - 62 -181 61 63 68.6 82.85 100 101.9 101.4
Net income 1 - 41 - 44 39 -135 54 47 53.15 64.05 77.6 78.4 78.1
Net margin - - - 17.39% 14.13% -49.82% 18.43% 16.55% 17.62% 19.98% 22.56% 21.85% 21.54%
EPS 2 - 0.3000 - 0.3100 - -0.9800 0.3800 0.3400 0.3850 0.4700 0.5700 0.5800 0.5800
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/16/22 4/28/22 7/28/22 4/27/23 7/27/23 11/9/23 2/22/24 4/25/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 821 573 860 534 77 287 587 927
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 149 -197 339 -227 -413 250 279 474
ROE (net income / shareholders' equity) - - - 133% 875% 206% 94.1% 55.7%
ROA (Net income/ Total Assets) - - - - - 14.5% 15.4% 14.8%
Assets 1 - - - - - 1,798 2,151 2,976
Book Value Per Share 2 - - - 0.3700 - 1.630 4.230 7.260
Cash Flow per Share 2 - - - - - 2.130 2.650 2.580
Capex 1 7 4 14 5 8 6.77 20.4 8.98
Capex / Sales 0.89% 0.62% 1.77% 0.55% 0.73% 0.54% 1.44% 0.57%
Announcement Date 2/13/20 2/18/21 2/16/22 2/16/23 2/22/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.35 USD
Average target price
30.82 USD
Spread / Average Target
+100.71%
Consensus
  1. Stock Market
  2. Equities
  3. INDV Stock
  4. Financials Indivior PLC